PROT-RESIST | Toward the Commercialization of a Proteolytically Resistant APPI Variant for Inhibiting Metastasis in Prostate and Pancreatic Cancer
01-11-2019
-30-04-2021
01-11-2019
-30-04-2021
01-03-2017
-31-08-2018
01-04-2015
-31-03-2021
01-03-2016
-28-02-2018
01-09-2019
-12-02-2022
01-02-2019
-31-01-2025
01-04-2019
-31-03-2025
01-03-2020
-31-07-2026
01-01-2023
-30-06-2025
01-07-2022
-30-06-2027
01-09-2023
-31-08-2028
01-01-2021
-31-12-2026
01-02-2021
-31-01-2027
01-09-2020
-31-08-2026
01-01-2023
-31-12-2027
01-05-2023
-30-04-2029
01-09-2024
-31-08-2029